Akasaka S - Search Results

1

The hypothalamo-pituitary axis responses to lipopolysaccharide-induced endotoxemia in mice lacking inducible nitric oxide synthase.

Akasaka S, Nomura M, Nishii H, Fujimoto N, Ueta Y, Tsutsui M, Shimokawa H, Yanagihara N, Matsumoto T. Akasaka S, et al. Brain Res. 2006 May 17;1089(1):1-9. doi: 10.1016/j.brainres.2006.02.112. Epub 2006 May 2. Brain Res. 2006. PMID: 16631135

2

Diagnosis of retrovesical ectopic and hyperplastic prostate tissue by transrectal needle biopsy.

Hamasaki T, Akasaka S, Yamaguchi R, Inatomi H, Takahashi K, Matsumoto T, Okamoto S. Hamasaki T, et al. Among authors: akasaka s. Urol Int. 2001;66(3):171-3. doi: 10.1159/000056603. Urol Int. 2001. PMID: 11316985 Review.

3

Emergence of cephem- and aztreonam-high-resistant Neisseria gonorrhoeae that does not produce beta-lactamase.

Akasaka S, Muratani T, Yamada Y, Inatomi H, Takahashi K, Matsumoto T. Akasaka S, et al. J Infect Chemother. 2001 Mar;7(1):49-50. doi: 10.1007/s101560170034. J Infect Chemother. 2001. PMID: 11406757

4

Outbreak of cefozopran (penicillin, oral cephems, and aztreonam)-resistant Neisseria gonorrhoeae in Japan.

Muratani T, Akasaka S, Kobayashi T, Yamada Y, Inatomi H, Takahashi K, Matsumoto T. Muratani T, et al. Among authors: akasaka s. Antimicrob Agents Chemother. 2001 Dec;45(12):3603-6. doi: 10.1128/AAC.45.12.3603-3606.2001. Antimicrob Agents Chemother. 2001. PMID: 11709349 Free PMC article.

5

[Screening for prostate cancer in Yahata, Kitakyushu].

Fujimoto N, Harada S, Sato H, Akasaka S, Nomura M, Yamada Y, Ueno Y, Matsumoto T. Fujimoto N, et al. Among authors: akasaka s. J UOEH. 2004 Jun 1;26(2):239-44. doi: 10.7888/juoeh.26.239. J UOEH. 2004. PMID: 15244076 Japanese.

6

Single dose 1 g ceftriaxone for urogenital and pharyngeal infection caused by Neisseria gonorrhoeae.

Muratani T, Inatomi H, Ando Y, Kawai S, Akasaka S, Matsumoto T. Muratani T, et al. Among authors: akasaka s. Int J Urol. 2008 Sep;15(9):837-42. doi: 10.1111/j.1442-2042.2008.02100.x. Epub 2008 Jul 25. Int J Urol. 2008. PMID: 18665871

7

Efficacy of estramustine phosphate according to risk classification of castration-resistant prostate cancer.

Minato A, Fujimoto N, Kubo T, Harada S, Akasaka S, Matsumoto T. Minato A, et al. Among authors: akasaka s. Med Oncol. 2012 Dec;29(4):2895-900. doi: 10.1007/s12032-012-0178-z. Epub 2012 Feb 10. Med Oncol. 2012. PMID: 22323054

8

The efficacy of sequential therapy using pazufloxacin followed by oral fluoroquinolones for treatment of pyelonephritis.

Takahashi K, Muratani T, Akasaka S, Yamada Y, Matsumoto T. Takahashi K, et al. Among authors: akasaka s. J Infect Chemother. 2013 Jun;19(3):456-64. doi: 10.1007/s10156-012-0505-5. Epub 2012 Nov 28. J Infect Chemother. 2013. PMID: 23188166 Clinical Trial.

9

Association Between Body Mass Index and Outcomes in Patients With Urothelial Carcinoma Treated With Pembrolizumab.

Tomisaki I, Harada M, Sakano S, Terado M, Hamasuna R, Harada S, Matsumoto H, Akasaka S, Nagata Y, Minato A, Harada KI, Fujimoto N. Tomisaki I, et al. Among authors: akasaka s. Anticancer Res. 2023 Jan;43(1):269-274. doi: 10.21873/anticanres.16159. Anticancer Res. 2023. PMID: 36585166

10

Differential impact of proton pump inhibitor on survival outcomes of patients with advanced urothelial carcinoma treated with chemotherapy versus pembrolizumab.

Tomisaki I, Harada M, Sakano S, Terado M, Hamasuna R, Harada S, Matsumoto H, Akasaka S, Nagata Y, Minato A, Harada KI, Fujimoto N. Tomisaki I, et al. Among authors: akasaka s. Int J Urol. 2023 Sep;30(9):738-745. doi: 10.1111/iju.15151. Epub 2023 Jan 24. Int J Urol. 2023. PMID: 36693764

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters